Colorectal cancer (CRC) is one of the deadliest cancers worldwide, and one of the biggest challenges in treating it is therapy resistance. Many...

Many strategies have been employed for clinical colorectal cancer (CRC) therapy. However, current treatments face significant limitations, such as...

Traditionally, radiation, chemotherapy, and surgery have been the most common ways to remove and destroy malignant cells.

Hebrew University scientists have revealed the mechanism that allows a certain microbe to evade immune cells, giving hope in the treatment not only of...

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes....

Professor Kwang-Hyun Cho’s research team has recently been highlighted for their work on developing an original technology for cancer reversal...

A type of aggressive, treatment-resistant brain tumour has a distinct population of immune cells that support its growth, according to new research...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumour growth by increasing cancer stemness in an oestrogen...

UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive...

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published...